Pancreatic cancer: diagnosis via signature analysis -- MEDICA Trade Fair

Pancreatic cancer: diagnosis via signature analysis

Interview with Prof. Julia Mayerle, Deputy Director, Clinic and Polyclinic for Internal Medicine A, Greifswald University Medicine

Pancreatic cancer is one of the deadliest forms of cancer because it is difficult to diagnose and only presents with symptoms in the later stages. In the future, a laboratory test developed at the Greifswald University Medicine could make an early detection of this type of cancer and consequently a faster and better treatment possible.

08/03/2016

Photo: Smiling woman with short grey-black hair - Prof. Julia Mayerle; Copyright: private

Prof. Julia Mayerle; ©private

Graphic: The pancreas and the surrounding organs; Copyright: panthermedia.net/Alexilus

The pancreas is surrounded by different organs in the abdomen. Cancer can hardly be detected here using imaging; ©panthermedia.net/ Alexilus

Photo: Blood samples on a data sheet; Copyright: panthermedia.net/belchonok

The researchers isolated a signature for the diagnoses of pancreatic cancer from more than 1,000 metabolites and a tumor marker in patient blood; ©panthermedia.net/ belchonok

Photo: Timo Roth; Copyright: B. Frommann

© B. Frommann